Reuters/ Jim Young
If the merger goes through, it would quite possibly be the biggest of 2015 - Allergan has a market cap of $117 billion, and Pfizer is worth over $200 billion.
One of the reasons Allergan is worth so much is Botox, which had more than $2 billion in sales as of 2013.
One of the most common pharmaceutical products, Botox is currently known as an anti-wrinkle treatment. However, the drug has many other approved medical uses...